Medication Supply Disruption

posted Apr 9, 2018, 7:06 PM by Chong Ching Wern   [ updated Apr 9, 2018, 7:06 PM ]
9 April 2018 (Circular No. SP PPUM: 120/2018):

The following medications will be facing supply disruptions:

No.

Name of Medication

Formulary Category

Cause / Action by Pharmacy

Estimated Stock Recovery

Alternative Medication


    1)

Albumin Human 20%



Standard Formulary

· Production issues by Grifols Malaysia Sdn. Bhd.

· Usage is only reserved for critical cases.

Mid April 2018

None, other companies are also experiencing stock issues.

    2)

Co-Careldopa 25mg / 100mg (Sinemet) Tablet



Standard Formulary

· Production issues by Menarini Singapore Pte. Ltd.

· Sort out supply from other suppliers.

Late June 2018

None, other companies are also experiencing stock issues.

    3)

Methotrexate 2.5mg Tablet

Standard Formulary

· Delay in stock delivery issues by Pfizer (M) Sdn. Bhd.

· Restricted to monthly supply only.

January 2019

None, Pfizer (M) Sdn. Bhd. is the sole manufacturer of the medication.

    4)

Potassium Dihydrogen Phosphate 10mmol/10mL Injection



Standard Formulary

· Delay in stock delivery issues by Pfizer (M) Sdn. Bhd.

· Ward stock supply will be temporarily ceased and prescription will be required for every supply.

Early June 2018

Consider use of
Neutral Phosphate Oral Solution:
Every 10mL of Neutral Phosphate Solution contains sodium 9.7mmol, phosphate 5.4mmol (elemental phosphate 166mg).